Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2026-03-06 @ 1:58 AM
Study NCT ID:
NCT06258668
Status:
RECRUITING
Last Update Posted:
2024-11-06
First Post:
2024-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IM011-1122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None